Cover Image

Macrolide Therapy in Chronic Inflammatory Diseases

Saved in:

Bibliographic Details
Main Authors:	Kazuhito Asano (Author), Elżbieta Tryka (Author), Joong Saeng Cho (Author), Naoto Keicho (Author)
Format:	Book
Published:	Hindawi Limited, 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Macrolide Therapy in Chronic Inflammatory Diseases
by: Brygida Kwiatkowska, et al.
Published: (2012)

Macrolides in Chronic Inflammatory Skin Disorders
by: Abdullateef A. Alzolibani, et al.
Published: (2012)

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
by: Toshikazu Shimane, et al.
Published: (2001)

Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
by: Ken-Ichi Kanai, et al.
Published: (2004)

Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo
by: Mayumi Suzuki, et al.
Published: (2002)

Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
by: Hajime Terao, et al.
Published: (2003)

Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999)

Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro
by: Jun-ichi Ito, et al.
Published: (2000)

Macrolide Allergic Reactions
by: Kristy M. Shaeer, et al.
Published: (2019)

Macrolide Therapy in Respiratory Viral Infections
by: Jin-Young Min, et al.
Published: (2012)

Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
by: Helen C. Steel, et al.
Published: (2012)

Azithromycin macrolids with a potent activity on chronic experimental toxopiasmosis
by: Sabah Saeid Mahmoud
Published: (2006)

Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
by: Carmen Rodriguez-Cerdeira, et al.
Published: (2012)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental <i>Mycoplasma pneumoniae</i> Pneumonia Unresponsive to Initial Macrolide Monotherapy
by: Eunha Bae, et al.
Published: (2022)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant pneumonia
by: Young Ho Seo, et al.
Published: (2014)

Use of macrolides in lung diseases: recent literature controversies
by: Luiz Vicente Ribeiro Ferreira da Silva Filho, et al.
Published: (2015)

Use of macrolides in lung diseases: recent literature controversies
by: Luiz Vicente Ribeiro Ferreira da Silva Filho, et al.
Published: (2015)

Possibilities of «New» Macrolides in the Treatment of Bacterial Respiratory Diseases
by: Ye.I. Yulish
Published: (2013)

Suppressive activity of a macrolide antibiotic, roxithromycin on co-stimulatory molecule expression on mouse splenocytes in vivo
by: K. Kawazu, et al.
Published: (2000)

Voltammetric study of the partitioning of macrolide antibiotics at the water/nitrobenzene interface. Relationship to the pharmacokinetic profiling of macrolides
by: Zoran Mandic
Published: (2014)

Macrolide treatment for COVID-19
by: Masashi Ohe
Published: (2022)

Macrolide resistance in Streptococcus species
by: A Ilakkiya, et al.
Published: (2015)

Place of Semisynthetic Penicillins and Macrolides in Antibiotic Therapy for Respiratory Infections in Children
by: A.Ye. Abaturov, et al.
Published: (2014)

The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
by: Leng M, et al.
Published: (2024)

Prevalence and clinical manifestations of macrolide resistant pneumonia in Korean children
by: Eun Lee, et al.
Published: (2017)

Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
by: Carlos F. Amábile-Cuevas
Published: (2023)

Macrolides in the Treatment of Respiratory Diseases in Children Caused by Extra- and Intracellular Microorganisms
by: Ye.I. Yulish, et al.
Published: (2014)

Pediatric periorificial dermatitis in an Asian population: A comparative study of oral metronidazole and oral macrolides
by: Jeewoo Kang, MD, et al.
Published: (2024)

Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods
by: Ying Chen, et al.
Published: (2024)

Natamycin - antimycotic of polyene macrolides class with unusual properties
by: I. O. Malova, et al.
Published: (2017)

The Role of Macrolides in Childhood Non-Cystic Fibrosis-Related Bronchiectasis
by: R. Masekela, et al.
Published: (2012)

Telitromicine. A new therapeutic option from macrolides to ketolides.
by: Pedro Miguel Milián Vázquez, et al.
Published: (2004)

Telitromicine. A new therapeutic option from macrolides to ketolides.
by: Pedro Miguel Milián Vázquez, et al.
Published: (2004)

Prevalence of Genotypes That Determine Resistance of Staphylococci to Macrolides and Lincosamides in Serbia
by: Milena Mišić, et al.
Published: (2017)

Mechanism of resistance acquisition and treatment of macrolide-resistant pneumonia in children
by: Hyeon-Jong Yang, et al.
Published: (2017)

Benefits and risks of therapeutic alternatives for macrolide resistant pneumonia in children
by: Hyeon-Jong Yang
Published: (2019)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant pneumonia
by: Eun-Ae Yang, et al.
Published: (2017)

Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae
by: Chi Eun Oh, et al.
Published: (2010)

C. acnes qPCR-Based Antibiotics Resistance Assay (ACQUIRE) Reveals Widespread Macrolide Resistance in Acne Patients and Can Eliminate Macrolide Misuse in Acne Treatment
by: Jingheng Zhang, et al.
Published: (2022)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
by: Louisa Warryn, et al.
Published: (2020)